IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,672 | +10.6% | 588 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $24,126 | +14.4% | 588 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $21,087 | +126.0% | 590 | +138.9% | 0.00% | +100.0% |
| Q4 2022 | $9,329 | -28.2% | 247 | -16.8% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | +30.0% | 297 | +12.9% | 0.00% | +100.0% |
| Q2 2022 | $10,000 | 0.0% | 263 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 267 | -21.5% | 0.00% | 0.0% |
| Q4 2021 | $10,000 | -37.5% | 340 | -27.0% | 0.00% | -50.0% |
| Q3 2021 | $16,000 | +700.0% | 466 | +703.4% | 0.00% | – |
| Q2 2021 | $2,000 | -83.3% | 58 | -78.1% | 0.00% | -100.0% |
| Q1 2021 | $12,000 | -14.3% | 265 | +3.9% | 0.00% | -33.3% |
| Q4 2020 | $14,000 | +133.3% | 255 | +119.8% | 0.00% | +200.0% |
| Q3 2020 | $6,000 | +200.0% | 116 | +182.9% | 0.00% | – |
| Q2 2020 | $2,000 | -91.3% | 41 | -91.6% | 0.00% | -100.0% |
| Q1 2020 | $23,000 | +2200.0% | 490 | +2030.4% | 0.00% | – |
| Q4 2019 | $1,000 | -91.7% | 23 | -89.4% | 0.00% | -100.0% |
| Q3 2019 | $12,000 | +1100.0% | 218 | +847.8% | 0.00% | – |
| Q2 2019 | $1,000 | -98.1% | 23 | -96.6% | 0.00% | -100.0% |
| Q1 2019 | $53,000 | +5200.0% | 676 | +2839.1% | 0.01% | – |
| Q4 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 23 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 23 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -50.0% | 23 | -74.7% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | -80.0% | 91 | -49.2% | 0.00% | -85.7% |
| Q4 2015 | $10,000 | – | 179 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |